# A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

> **NCT00528411** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 123 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Ticagrelor Tablets
- **DRUG:** Clopidogrel (over encapsulated) capsule
- **DRUG:** Aspirin Tablets

## Key facts

- **NCT ID:** NCT00528411
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 123 (ACTUAL)
- **Last updated:** 2012-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00528411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00528411, "A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00528411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*